Register entry

Actelion Pharmaceuticals US, Inc.

Registered sites
0
Drug products
21
Live patents
149
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

149

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
OPSUMITMACITENTANSept 2026
OPSUMITMACITENTANMar 2027
OPSUMITMACITENTANMay 2027
OPSUMITMACITENTANNov 2027
OPSUMITMACITENTANOct 2028
OPSUMITMACITENTANApr 2029
OPSUMITMACITENTANApr 2029
OPSUMITMACITENTANOct 2029
OPSYNVIMACITENTAN; TADALAFILSept 2026
OPSYNVIMACITENTAN; TADALAFILMar 2027
OPSYNVIMACITENTAN; TADALAFILApr 2029
OPSYNVIMACITENTAN; TADALAFILOct 2029
TRACLEERBOSENTANDec 2027
UPTRAVISELEXIPAGOct 2026
UPTRAVISELEXIPAGApr 2027
UPTRAVISELEXIPAGAug 2029
UPTRAVISELEXIPAGFeb 2030
UPTRAVISELEXIPAGJun 2030
UPTRAVISELEXIPAGAug 2030
UPTRAVISELEXIPAGDec 2030
UPTRAVISELEXIPAGFeb 2031
UPTRAVISELEXIPAGDec 2036
UPTRAVISELEXIPAGJun 2037
VELETRIEPOPROSTENOL SODIUMFeb 2027
VELETRIEPOPROSTENOL SODIUMMar 2027
Catalogue

Marketed products

21

Showing 21 of 21.

BrandGeneric nameFormCategory
OPSUMITmacitentanTABLET, FILM COATEDNDA
OPSYNVImacitentan and tadalafilTABLET, FILM COATEDNDA
OPSYNVImacitentan and tadalafilTABLET, FILM COATEDNDA
TracleerbosentanTABLET, FILM COATEDNDA
TracleerbosentanTABLET, FILM COATEDNDA
TracleerbosentanTABLET, FOR SUSPENSIONNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagTABLET, COATEDNDA
UPTRAVISelexipagINJECTION, POWDER, FOR SOLUTIONNDA
UPTRAVISelexipagTABLET, FILM COATEDNDA
UPTRAVISelexipagTABLET, FILM COATEDNDA
UPTRAVI Titration PackSelexipagKITNDA
VeletriepoprostenolINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
VeletriepoprostenolINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
ZavescamiglustatCAPSULENDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.